Genertec Universal Medical Group Co Ltd
HKEX:2666

Watchlist Manager
Genertec Universal Medical Group Co Ltd Logo
Genertec Universal Medical Group Co Ltd
HKEX:2666
Watchlist
Price: 4.91 HKD -0.2% Market Closed
Market Cap: 9.3B HKD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one Genertec Universal Medical Group Co Ltd stock under the Base Case scenario is 22.81 HKD. Compared to the current market price of 4.91 HKD, Genertec Universal Medical Group Co Ltd is Undervalued by 78%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
22.81 HKD
Undervaluation 78%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
63
vs Industry
81
Median 3Y
0.6
Median 5Y
0.7
Industry
3
Forward
0.6
More Details
4.3
P/E
P/E
Price to Earnings
4.3
vs History
38
vs Industry
61
Median 3Y
4
Median 5Y
4.2
Industry
14.2
Forward
3.9
More Details
7.7
P/OCF
P/OCF
Price to OCF
7.7
vs History
14
vs Industry
51
Median 3Y
3.9
Median 5Y
1.6
Industry
9.4
More Details
34.6
P/FCFE
P/FCFE
Price to FCFE
34.6
vs History
14
vs Industry
9
Median 3Y
11.3
Median 5Y
8.1
Industry
12
More Details
0.5
P/B
P/B
Price to Book Value
0.5
vs History
66
vs Industry
76
Median 3Y
0.5
Median 5Y
0.5
Industry
1.2
More Details
3
EV/S
EV/S
Enterprise Value to Sales
3
vs History
74
vs Industry
52
Median 3Y
3.1
Median 5Y
3.2
Industry
4.6
Forward
2.7
More Details
9.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.1
vs History
42
vs Industry
31
Median 3Y
9.2
Median 5Y
8.8
Industry
6.9
More Details
13.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
13.1
vs History
33
vs Industry
35
Median 3Y
13.1
Median 5Y
11.9
Industry
13.6
Forward
11.6
More Details
16.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.1
vs History
14
vs Industry
28
Median 3Y
15.6
Median 5Y
13.5
Industry
13.9
Forward
12.7
More Details
36.6
EV/OCF
EV/OCF
Enterprise Value to OCF
36.6
vs History
14
vs Industry
38
Median 3Y
16.7
Median 5Y
7.3
Industry
11.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
33
Median 3Y
8.3
Median 5Y
-5.6
Industry
12.8
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
52
vs Industry
60
Median 3Y
0.5
Median 5Y
0.5
Industry
0.9
More Details

Multiples Across Competitors

Competitors Multiples
Genertec Universal Medical Group Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Genertec Universal Medical Group Co Ltd
HKEX:2666
9.3B HKD 0.6 4.3 13.1 16.1
IN
Indian Railway Finance Corp Ltd
NSE:IRFC
1.7T INR 6.3 25.8 21.5 21.5
IN
Power Finance Corporation Ltd
NSE:PFC
1.4T INR 1.4 6.1 10.4 10.4
IN
REC Limited
NSE:RECLTD
1.1T INR 2.1 7.1 31.9 32
JP
Shinkin Central Bank
TSE:8421
1.8T JPY 6.7 73.8 1 142.5 0
JP
Mitsubishi HC Capital Inc
TSE:8593
1.4T JPY 0.7 11 15.3 47.2
CA
Element Fleet Management Corp
TSX:EFN
12.6B CAD 6 33.1 20.4 50
TW
Chailease Holding Company Ltd
TWSE:5871
191.3B TWD 1.9 8.7 12.3 15.7
IN
Indian Renewable Energy Development Agency Ltd
NSE:IREDA
450.3B INR 6.7 26.5 45.5 46.3
IN
Housing and Urban Development Corporation Ltd
NSE:HUDCO
440.9B INR 4.6 16.4 15 15
JP
Tokyo Century Corp
TSE:8439
721.1B JPY 0.5 8.3 10.8 35.5

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 249,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.